Since LAP3 can be detected in serum, we next measured LAP3 expression in serum by western blotting and the result exhibited that LAP3 was significantly increased in serum of HFD-induced NASH animal model (Figure 1H and 1I). This evidence concerns the gene LAP3 and metabolic dysfunction-associated steatohepatitis.